- CYP17 Gene Polymorphism and its Association in North Indian Prostate Cancer Patients
[作者：Sobti, RC; Gupta, L; Thakur, H; Seth, A; Singh, SK; Kaur, P,期刊：Anticancer Research, 页码：1659-1663 , 文章类型： Article，,卷期：2009年29-5]
- Background: The CYP17 gene codes for the cytochrome P450c17a enzyme, which mediates two key steps in sex steroid synthesis In this studs,, the association between CYP17 polymorphism and the risk of prostate cancer in com...
- Gastric Perforation Presenting as Empyema in a Patient with Pancreatic Cancer on Bevacizumab Treatment
[作者：Shao, YY; Lin, ZZ; Liang, PC; Tien, YW; Cheng, AL,期刊：Anticancer Research, 页码：1665-1667 , 文章类型： Article，,卷期：2009年29-5]
- Bowel perforation is a rare but life-threatening complication of bevacizumab, a new anticancer treatment. Patients with bowel perforation usually present with acute abdominal symptoms. Here a case history is presented to...
- Clinicopathological Features of Perforated Colorectal Cancer
[作者：Ogawa, M; Watanabe, M; Eto, K; Omachi, T; Kosuge, M; Hanyu, K; Noaki, L; Fujita, T; Yanaga, K,期刊：Anticancer Research, 页码：1681-1684 , 文章类型： Article，,卷期：2009年29-5]
- The aim of this retrospective study was to determine clinicopathological factors pertinent to the prognosis of perforated colorectal cancer (PCRC). Patients and Methods: A retrospective review of clinical records of 17 c...
- Expression of Matriptase and Clinical Outcome of Human Endometrial Cancer
[作者：Nakamura, K; Hongo, A; Kodama, J; Abarzua, F; Nasu, Y; Kumon, H; Hiramatsu, Y,期刊：Anticancer Research, 页码：1685-1690 , 文章类型： Article，,卷期：2009年29-5]
- Background: Matriptase, a type II transmembrane serine protease is involved in angiogenesis, degradation of extracellular matrix and in progression of some epithelial cancers. The purpose of the present study was to exam...
- Immunohistochemical Detection of WT1 Protein in Endometrial Cancer
[作者：Ohno, S; Dohi, S; Ohno, Y; Kyo, S; Sugiyama, H; Suzuki, N; Inoue, M,期刊：Anticancer Research, 页码：1691-1695 , 文章类型： Article，,卷期：2009年29-5]
- Background: The Wilms' tumor gene WT1 is overexpressed in various kinds of solid tumors. However, it remains unclear whether WT1 plays a pathophysiological role in endometrial cancer. Patients and Methods: A series of 70...
- Prognosis for Isolated Skin Recurrence after Breast Cancer Treated by Mastectomy
[作者：Jaffre, F; Lavoue, V; Mesbah, H; Rouquette, S; Audrain, O; Laurent, JF; Leveque, J,期刊：Anticancer Research, 页码：1697-1701 , 文章类型： Article，,卷期：2009年29-5]
- Isolated skin recurrence after mastectomy (ISRAM) for breast cancer is a rare event for which treatment is difficult and subject to debate. Patients and Methods: The records of 75 patients presenting with ISRAM were revi...
- Kinetics of HER2/neu ECD in 45 Patients Treated with Trastuzumab (Herceptin (R)) between January 2001 and June 2005 at the Grenoble University Hospital
[作者：Gauchez, AS; Colonna, M; Brand, FX; Ravanel, N; Pasquier, D; Payan, R; Mousseau, M,期刊：Anticancer Research, 页码：1703-1707 , 文章类型： Article，,卷期：2009年29-5]
- The aim of this study was to evaluate the utility of HER2/neu ECD concentration as a marker of the efficacity of clinical response to Herceptin (R). Patients and Methods: Iterative measurements of HER2/neu ECD (ELISA c-e...
- GSTM1 and NAT2 Polymorphisms and Colon, Lung and Bladder Cancer Risk: A Case-control Study
[作者：Zupa, A; Sgambato, A; Bianchino, G; Improta, G; Grieco, V; La Torre, G; Campisi, B; Traficante, A; Aieta, M; Cittadini, A,期刊：Anticancer Research, 页码：1709-1714 , 文章类型： Article，,卷期：2009年29-5]
- Background: Glutathione S-transferase M1 (GSTM1) and N-acelyltransferase-2 (NAT2) are phase II enzymes involved in the metabolism of xenobiotics and whose polymorphisms have been related to individual cancer risks. Patie...
- Human Papillomavirus Infection as a Prognostic Factor in Oropharyngeal Squamous Cell Carcinomas Treated in a Prospective Phase II Clinical Trial
[作者：Jo, S; Juhasz, A; Zhang, KQ; Ruel, C; Loera, S; Wilczynski, SP; Yen, Y; Liu, XY; Ellenhorn, J; Lim, D; Paz, B; Somlo, G; Vora, N; Shibata, S,期刊：Anticancer Research, 页码：1467-1474 , 文章类型： Article，,卷期：2009年29-5]
- The aim of this study was to determine the presence of high-risk HPV-16 in patients with HNSCC, assess the impact of HPV status on treatment response and survival in this select cohort treated with combined modality ther...
- Urokinase-type Plasminogen Activator and Plasminogen-activator-inhibitor Type 1 Predict Metastases in Good Prognosis Breast Cancer Patients
[作者：de Cremoux, P; Grandin, L; Dieras, V; Savignoni, A; Degeorges, A; Salmon, R; Bollet, MA; Reyal, F; Sigal-Zafrani, B; Vincent-Salomon, A; Sastre-Garau, X; Magdelenat, H; Mignot, L; Fourquet, A,期刊：Anticancer Research, 页码：1475-1482 , 文章类型： Article，,卷期：2009年29-5]
- This retrospective analysis was designed to confirm the predictive role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type I (PAI-1) in the outcome of early stage, node-negative breast...
- Lymph-vascular Space Involvement and Outer One-third Myometrial Invasion Are Strong Predictors of Distant Haematogeneous Failures in Patients with Stage I-II Endometrioid-type Endometrial Cancer
[作者：Gadducci, A; Cavazzana, A; Cosio, S; Di Cristofano, C; Tana, R; Fanucchi, A; Teti, G; Cristofani, R; Genazzani, AR,期刊：Anticancer Research, 页码：1715-1720 , 文章类型： Article，,卷期：2009年29-5]
- The aim of this retrospective study was to assess the predictive value of different clinicopathological variables (patient age, tumour size, FIGO grade, myometrial invasion, lymph-vascular space involvement [LVSI], invas...
- Comparison of Antiemetic Efficacy between Single and Repeated Treatments with a 5-HT3 Receptor Antagonist in Breast Cancer Patients with High-risk Emetogenic Chemotherapy
[作者：Taguchi, K; Iihara, H; Ishihara, M; Komori, Y; Tanizawa, K; Matsuura, K; Itoh, Y,期刊：Anticancer Research, 页码：1721-1725 , 文章类型： Article，,卷期：2009年29-5]
- Background: The significance of repeated treatment with the 5-HT3 receptor antagonist for prophylaxis of chemotherapy-induced emesis remains to be clarified. Patients and Methods: A retrospective analysis was performed t...
- A Randomized Controlled Trial Investigating the Effects of Celecoxib in Patients with Localized Prostate Cancer
[作者：Sooriakumaran, P; Coley, HM; Fox, SB; Macanas-Pirard, P; Lovell, DP; Henderson, A; Eden, CG; Miller, PD; Langley, SEM; Laing, RW,期刊：Anticancer Research, 页码：1483-1488 , 文章类型： Article，,卷期：2009年29-5]
- Cyclooxygenase-2 (COX-2) is associated with tumour promotion, inhibition of apoptosis, angiogenesis and metastasis. Celecoxib, a selective COX-2 inhibitor was investigated, in patients with clinically localized prostate ...
- ErbB 1-4 Expression Alterations in Primary Colorectal Cancers and their Corresponding Metastases
[作者：Ljuslinder, I; Malmer, B; Isaksson-Mettavainio, M; Oberg, A; Henriksson, R; Stenling, R; Palmqvist, R,期刊：Anticancer Research, 页码：1489-1494 , 文章类型： Article，,卷期：2009年29-5]
- Background: EGFR (epidermal growth factor receptor) targeted therapies are important new tools in colorectal cancer treatment. EGFR analysis of the primary tumour was previously recommended to identify patients who will ...
|